ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00240305
Recruitment Status : Completed
First Posted : October 18, 2005
Last Update Posted : March 16, 2009
Sponsor:
Information provided by:
AstraZeneca